Piomic’s COMS Technology Validated with New Potential Applications
Piomic, part of Serpentine Ventures, saw its technology reconfirmed as highly effective in a recent study, showcasing significant wound reduction and ease of use. New potential applications include autolytic debridement and pressure ulcers.